Is the routine use of trimodality therapy for selected patients with non-small cell lung cancer supported by long-term clinical outcomes?

Sorry, there's nothing here.

Cite this paper

@article{Dickhoff2017IsTR, title={Is the routine use of trimodality therapy for selected patients with non-small cell lung cancer supported by long-term clinical outcomes?}, author={Chris Dickhoff and Koen J. Hartemink and Julian F. P. Kooij and Peter M van de Ven and Marinus A. Paul and Egbert F. Smit and Max R. Dahele}, journal={Annals of oncology : official journal of the European Society for Medical Oncology}, year={2017}, volume={28 1}, pages={185} }